FIELD: medicine.
SUBSTANCE: invention can be used in the pharmaceutical industry and relates to an application of (S)-2-(((4'-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methanesulphonate as an active ingredient of a medicinal product for preventing and treating a stroke.
EFFECT: invention provides a possibility of reducing the size of the infarct focus in the inner capsule of the brain and restoring the motor function disorder caused by a stroke.
4 cl, 9 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR PREVENTION AND TREATMENT OF SPINAL CORD INJURY | 2019 |
|
RU2750201C1 |
| ALPHA-AMINOAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREWITH | 2015 |
|
RU2673622C2 |
| COMPOSITION FOR PREVENTION, RELIEF OF SYMPTOMS, OR TREATMENT OF NEURODEGENERATIVE DISEASES, CONTAINING PEDIOCOCCUS INOPINATUS | 2020 |
|
RU2791695C2 |
| USING TREATED GINSENG EXTRACT AND SAPONINS ISOLATED FROM ITS | 2003 |
|
RU2294208C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DEGENERATIVE BRAIN DISEASE COMPRISING GLYCINE TRANSPORTER AS ACTIVE INGREDIENT | 2021 |
|
RU2816256C1 |
| α-AMINOAMIDE DERIVATIVES EFFECTIVE IN TREATING RESTLESS LEGS SYNDROME AND ADDICTIVE DISORDERS | 2005 |
|
RU2403030C2 |
| NEW COMPOUND FOR DIRECT INHIBITION OF ASM ACTIVITY, WHICH IS DERIVATIVE OF 2-AMINO-2-(1,2,3-TRIAZOL-4-YL)PROPANE-1,3-DIOL, AND ITS APPLICATION | 2019 |
|
RU2759856C1 |
| THERAPEUTIC HERBAL EXTRACT HAVING ACTION ON OBESITY | 2008 |
|
RU2475256C2 |
| COMPOSITION FOR PREVENTING OR TREATING OBESITY CONTAINING A-LIPOIC ACID AND N-ACETYLCYSTEINE AS ACTIVE INGREDIENTS | 2015 |
|
RU2670612C9 |
| COMPOSITION CONTAINING HYALURONAN/PROTEOGLYCAN-BINDING PROTEIN 1 FOR PREVENTION OR TREATMENT OF LUNG DISEASES | 2021 |
|
RU2810732C1 |
